245 related articles for article (PubMed ID: 1933860)
1. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
Paganelli G; Magnani P; Zito F; Villa E; Sudati F; Lopalco L; Rossetti C; Malcovati M; Chiolerio F; Seccamani E
Cancer Res; 1991 Nov; 51(21):5960-6. PubMed ID: 1933860
[TBL] [Abstract][Full Text] [Related]
2. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
[TBL] [Abstract][Full Text] [Related]
4. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
6. Three-step tumor pre-targeting in lung cancer immunoscintigraphy.
Dosio F; Magnani P; Paganelli G; Samuel A; Chiesa G; Fazio F
J Nucl Biol Med (1991); 1993 Dec; 37(4):228-32. PubMed ID: 8172965
[TBL] [Abstract][Full Text] [Related]
7. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
8. Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma.
Li GP; Zhang H; Zhu CM; Zhang J; Jiang XF
World J Gastroenterol; 2005 Oct; 11(40):6288-94. PubMed ID: 16419157
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
Barbet J; Peltier P; Bardet S; Vuillez JP; Bachelot I; Denet S; Olivier P; Leccia F; Corcuff B; Huglo D; Proye C; Rouvier E; Meyer P; Chatal JF
J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
[TBL] [Abstract][Full Text] [Related]
10. Preoperative and intraoperative radioimmunodetection of cancer pretargeted by biotinylated monoclonal antibodies.
Di Carlo V; De Nardi P; Stella M; Magnani P; Fazio F
Semin Surg Oncol; 1998 Dec; 15(4):235-8. PubMed ID: 9829379
[TBL] [Abstract][Full Text] [Related]
11. Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
Griffin TW; Brill AB; Stevens S; Collins JA; Bokhari F; Bushe H; Stochl MC; Gionet M; Rusckowski M; Stroupe SD
J Clin Oncol; 1991 Apr; 9(4):631-40. PubMed ID: 2066759
[TBL] [Abstract][Full Text] [Related]
12. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110.
Divgi CR; McDermott K; Johnson DK; Schnobrich KE; Finn RD; Cohen AM; Larson SM
Int J Rad Appl Instrum B; 1991; 18(7):705-10. PubMed ID: 1787079
[TBL] [Abstract][Full Text] [Related]
14. Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate.
Chetanneau A; Barbet J; Peltier P; Le Doussal JM; Gruaz-Guyon A; Bernard AM; Resche I; Rouvier E; Bourguet P; Delaage M
Nucl Med Commun; 1994 Dec; 15(12):972-80. PubMed ID: 7715897
[TBL] [Abstract][Full Text] [Related]
15. Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.
Wang Z; Garkavij M; Ohlsson T; Strand SE; Sjögren HO; Tennvall J
Cancer Biother Radiopharm; 2003 Jun; 18(3):365-75. PubMed ID: 12954123
[TBL] [Abstract][Full Text] [Related]
16. Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin.
Paganelli G; Magnani P; Zito F; Lucignani G; Sudati F; Truci G; Motti E; Terreni M; Pollo B; Giovanelli M
Eur J Nucl Med; 1994 Apr; 21(4):314-21. PubMed ID: 8005155
[TBL] [Abstract][Full Text] [Related]
17. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
Vuillez JP; Moro D; Brichon PY; Rouvier E; Brambilla E; Barbet J; Peltier P; Meyer P; Sarrazin R; Brambilla C
J Nucl Med; 1997 Apr; 38(4):507-11. PubMed ID: 9098191
[TBL] [Abstract][Full Text] [Related]
18. Imaging of recurrent intestinal carcinoma with indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody CEA102.
Nakada K; Sakamoto J; Watanabe T; Itoh K; Akiyama S; Takagi H
Jpn J Cancer Res; 1997 Jun; 88(6):605-13. PubMed ID: 9263539
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the 111In-(Sn)-citrate method to label antibodies for radioimmunotargeting studies.
Nakamura K; Ruiz-Juvera A; Kubo A; Hashimoto S
Int J Rad Appl Instrum B; 1992 Jan; 19(1):21-5. PubMed ID: 1577610
[TBL] [Abstract][Full Text] [Related]
20. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]